Albireo
Albireo is a Massachusetts-based biopharmaceutical firm that researches and develops novel bile acid modulators for the treatment of liver diseases.
Business Model:
Revenue: $57.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Albireo Information
Geographic Data
Address: 53 State Street
City: Boston
State: MA
Zip: 02109
Country: US
Financial Info
Stage:
series a
Raised Last:
$40M
Raised Total:$40M
Social
Metrics
3,516,271Website Global Rank
3,443Website Monthly Traffic
Twitter Followers
Description
Albireo is a Massachusetts-based biopharmaceutical firm that researches and develops novel bile acid modulators for the treatment of liver diseases.
Contact Phone:
+18572545555
Contact Email:
Albireo went public on 11/4/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/4/2016
Ticker Symbol:
ALBO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2008 | Series A | 2 | $40M |
TVM Capital TPG Growth TVM Capital TPG Growth |
6/2020 | Debt | $80M |
Hercules Capital, Inc. |
6/2012 | Equity | $18.5M |
Allianz Global Investors |
5/2008 | Series A | $40M |
TPG Growth TVM Capital |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2016 | Biodel |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
